The GH Axis: How Endogenous Growth Hormone Release Works
Endogenous growth hormone is released in pulses, primarily during deep sleep, with smaller pulses during the day in response to exercise, fasting, and certain neurological signals. The pulse pattern is more important than the average circulating level: the body responds to the pulsatile pattern, not to a steady-state elevation, which is why exogenous recombinant growth hormone has a different physiological effect than peptide-driven endogenous release.
The pulses themselves are controlled by two opposing signals from the hypothalamus: growth hormone releasing hormone, GHRH, which tells the pituitary to release a pulse, and somatostatin, which tells it to stop. The interplay between these two signals shapes the timing and amplitude of every GH pulse the pituitary produces.
There is also a third input: ghrelin, the hunger hormone, which acts on a separate pituitary receptor and amplifies whatever pulse the GHRH-somatostatin balance is currently allowing. Ghrelin is the body's natural growth hormone secretagogue, and it is the receptor system that the synthetic GHRP class of peptides was designed to mimic.
Understanding this axis matters because the Ipamorelin and CJC-1295 combination is designed to act on both arms simultaneously: the GHRP arm through Ipamorelin, and the GHRH arm through CJC-1295. The synergy is not a marketing claim. It is built into the way the axis is constructed.
Ipamorelin Mechanism Deep Dive
Ipamorelin is a selective ghrelin receptor agonist. It binds the GHSR-1a receptor on the pituitary somatotrophs and triggers a growth hormone pulse, mimicking what endogenous ghrelin would do. The selectivity is the key feature: unlike older GHRPs in its class, Ipamorelin does not meaningfully drive cortisol or prolactin elevation, which is one of the reasons it has become the default GHRP choice in the educational literature.
The selectivity comes from its structure. Ipamorelin is a five-amino-acid sequence that fits the ghrelin receptor binding pocket cleanly without significant cross-reactivity at the corticotroph or lactotroph receptors that older compounds in its class hit as a side effect. This is why operators report cleaner subjective effects with Ipamorelin compared to GHRP-2 or GHRP-6.
The half-life is short, around 2 hours, which means a single Ipamorelin dose produces a single defined pulse rather than a sustained elevation. This pulse-mimicry pattern is part of why Ipamorelin pairs well with timing strategies built around natural pulse windows: pre-sleep and post-training are the two most-discussed.
The dose-response curve plateaus at the receptor saturation point, which sits around 100 mcg in most of the educational literature. Doses above 300 mcg do not appear to produce proportionally larger pulses because the receptor is already saturated, which is one of the reasons higher dosing does not necessarily translate to higher response.
CJC-1295 No DAC vs DAC: The Critical Difference
The single most important distinction in this section, and the one most often confused, is the difference between CJC-1295 with DAC and CJC-1295 without DAC. They are not the same molecule and they do not produce the same effect.
CJC-1295 without DAC, also called Modified GRF 1-29 or sometimes just Mod GRF, is a GHRH analog with a half-life of about 30 minutes. It produces a defined pulse of GHRH activity at the pituitary, which combines with the Ipamorelin GHRP pulse to drive a single, sharp, larger-than-baseline GH release. This is the version that pairs cleanly with Ipamorelin in the standard pulsatile protocol.
CJC-1295 with DAC, sometimes written CJC-1295 DAC, is the same GHRH peptide with a Drug Affinity Complex molecule attached that binds to circulating albumin and extends the half-life to 6 to 8 days. This converts the pulsatile signal into a sustained low-level elevation, which produces a flatter, more continuous GH bleed rather than a defined pulse pattern.
The educational consensus is that for combination with Ipamorelin, the No DAC version is the right pairing because it preserves the pulsatile pattern that the body is built to respond to. The DAC version produces a different physiological pattern, more like the steady-state elevation of recombinant GH, and it does not pair the same way with a pulsatile GHRP. Operators who use the DAC version typically do not stack it with Ipamorelin in the same protocol because the combination defeats the purpose of either approach.
Why the Two Together
The synergy story is mechanistic. A GHRP alone, like Ipamorelin by itself, can only produce a pulse as large as the somatostatin tone allows. If somatostatin is elevated, the pulse is smaller. A GHRH analog alone, like CJC-1295 No DAC by itself, also has to fight through whatever somatostatin tone is present.
When the two are dosed together, they hit the pituitary simultaneously from two different receptor systems. The combined signal overcomes the somatostatin brake more effectively than either signal alone, and the resulting GH pulse is consistently larger than the sum of what each compound would produce in isolation. This is the published synergy.
The practical implication is that the two compounds should be administered at the same time, not staggered. A typical educational protocol calls for both compounds drawn into the same syringe and injected together, so the pulse signals arrive at the pituitary in synchrony.
Educational Dosing Reference Table
The dosing references below are drawn from the consensus educational literature. They are not medical advice. They are the starting reference points operators converge on when they want to understand where to begin.
Timing: Pre-Sleep, Pre-Training, Or Both
The pre-sleep dose is the foundational dose in almost every educational protocol. The reason is that the largest natural GH pulse of the 24-hour cycle happens during the first deep sleep cycle, and the Ipamorelin/CJC-1295 combination dosed 30 minutes before bed amplifies that natural pulse rather than creating one out of nowhere. This is why the pre-sleep dose is the one operators report producing the most consistent subjective and lab-measured response.
The pre-training dose is the second most common. The rationale is that exercise itself triggers a natural GH pulse, and dosing before training amplifies that pulse the same way the pre-sleep dose amplifies the sleep pulse. The educational best practice is to dose 20 to 30 minutes before training begins, in a fasted state.
A mid-day fasted-window dose can be added for protocols targeting more aggressive GH exposure, but the trade-off is that more frequent dosing during the day requires more rigorous fasting discipline because each pulse window has to be clean. For most operators, the two-pulse pattern of pre-sleep and pre-training is the educational sweet spot.
The Fasted-State Requirement
Food kills the GH pulse. This is one of the most reliable findings in the GH-secretagogue literature, and it is the single most common reason an otherwise well-designed protocol produces a flat result.
The mechanism is the insulin response. When food is consumed, insulin rises, and elevated insulin suppresses GH release independently of whatever signal the GHRP and GHRH are sending to the pituitary. The somatostatin tone also rises in response to food, which compounds the suppression.
The educational standard is a minimum of 2 hours fasted before a dose and 30 minutes fasted after. Carbohydrates and protein are the two macronutrients with the largest insulin response, so a fully fasted window is the cleanest. Black coffee, water, and electrolyte drinks without sugar are the only things that should be in the system during the dosing window.
This is the rule operators most often try to bend, and it is the rule that produces the most flat results when bent. If the protocol is not producing the expected response, the fasting window is the first variable to audit.
IGF-1 as the Feedback Marker
IGF-1, insulin-like growth factor 1, is the downstream marker that operators track to evaluate whether a GH protocol is producing the expected systemic response. Growth hormone itself is too pulsatile to measure usefully on a single blood draw, but IGF-1 is produced primarily in the liver in response to GH exposure and circulates at a much steadier level, which makes it a clean marker for integrated GH activity over the previous several days.
The educational best practice is to measure baseline IGF-1 before starting the protocol, then measure again at the 4-week and 8-week marks. A meaningful response shows up as an IGF-1 elevation of 30 to 50 percent above baseline, depending on starting age, baseline level, and protocol intensity.
An IGF-1 that has not moved by week 4 is the strongest signal that something in the protocol is off. The most common causes, in order, are: fasted-state failure during dosing windows, reconstitution error producing under-dosing, supplier quality issues, and dosing the wrong CJC-1295 version (DAC instead of No DAC, or vice versa).
Subjective Markers Worth Tracking
IGF-1 is the primary objective marker, but operators running this stack also track subjective markers that often shift before the lab numbers do. Sleep depth is the most consistent: many operators report deeper sleep within the first week, particularly when the pre-sleep dose is timed correctly. Recovery from training is the second consistent marker, with operators reporting reduced delayed-onset muscle soreness and faster bounce-back from heavier sessions.
Skin and connective tissue feel is a third marker that often shows up in the literature. Some operators report subtle changes in skin quality and joint feel within the first 4 weeks, which fits with the GH-driven IGF-1 effects on those tissues.
Body composition shifts are the most variable subjective marker. Operators with controlled training and nutrition often report measurable recomposition over an 8-week cycle, while operators without that controlled context report more variable results. The compound is not a substitute for the foundational inputs, and the educational consensus is that GH-axis protocols amplify what the operator is already doing rather than producing changes independent of training and nutrition.
All of these subjective markers should be tracked alongside the objective lab markers to produce a full picture of the cycle response.
Side Effect Considerations
The Ipamorelin and CJC-1295 No DAC combination has a relatively clean side-effect profile in the educational literature, primarily because of the receptor selectivity of Ipamorelin and the pulsatile nature of the combined signal. The most common reported side effects are mild and transient.
Water retention can appear in the first 1 to 2 weeks of a cycle as the GH-axis activity increases tissue hydration. This typically resolves within 2 weeks as the body adapts. Persistent water retention beyond 2 weeks may indicate over-dosing or an issue with the specific compound version (DAC contamination in a No DAC vial, for example).
Mild fatigue or vivid dreams in the first week are sometimes reported as the deeper sleep cycles take hold. These are typically positive signals rather than problems, but they are worth tracking.
Numbness or tingling in the hands or fingers is a more significant signal that the GH activity is at the high end of the comfortable range. The educational response is to reduce the dose or extend the off-period, not to push through. Carpal tunnel symptoms are the body's signal that the protocol is more aggressive than the system can handle, and ignoring that signal compounds the problem.
Cycle Design
The standard educational cycle is 8 weeks on, 4 weeks off. The rationale is receptor sensitivity. The ghrelin receptor that Ipamorelin targets does not appear to downregulate as aggressively as some other peptide receptors, but the pituitary response over time can become less sharp without periodic washout, and the educational consensus is that an 8-week run followed by a 4-week off-period preserves response over the long term better than continuous use.
Some operators run shorter cycles, 4 weeks on and 2 weeks off, particularly when running multiple cycles per year. Others run longer, 12 weeks on and 4 weeks off, in protocols targeting specific recomposition windows. The 8-and-4 pattern is the most-discussed default.
The off-period is not optional in the educational framework. It is the time when baseline IGF-1 returns to its true baseline, which gives the operator a clean comparison point for the next cycle. Operators who run continuously without an off-period lose the ability to evaluate whether each cycle is producing the same response as the last.
When You Are Not Seeing IGF-1 Movement
If 4 weeks in, the IGF-1 has not moved meaningfully, the audit sequence is straightforward. Start with the fasting window: was it actually 2 hours clean before each dose, or was it 90 minutes with a small snack? Move to reconstitution: was the volume right, was the powder fully dissolved, was the vial stored correctly? Move to the compound itself: is it the No DAC version when the protocol assumed No DAC?
Supplier quality is the next variable. A vial that arrived warm or that came from a supplier with poor third-party verification may simply not contain what the label says. This is why the educational literature is increasingly insistent on third-party COA verification at the supplier selection stage.
If all of the above checks out and IGF-1 still has not moved, the next step is to reassess the dose. Some operators are at the lower end of the range when their baseline GH-axis function would benefit from the upper end. Others are at the upper end and may be saturating the receptor without producing additional response.
The Educational Framework
The Ipamorelin and CJC-1295 combination is one of the most-studied and most-used peptide stacks in the educational literature, and it is also one of the most-misunderstood, primarily because of the No DAC versus DAC confusion and the fasted-state issue.
The free Academy covers GH-axis protocols in detail, with reconstitution math, lab tracking templates, and the full cycling framework. None of this is medical advice. All of it is educational content for operators who want to understand the axis they are working with.
Join the free Academy
Get the full peptide education library, reconstitution worksheets, lab tracking templates, and the cycling framework.